Antinociceptive effects of systemic lidocaine: Involvement of the spinal glycinergic system

European Journal of Pharmacology

Volumn 613, Issue 1-3, 2009, Pages 68-73

  Muth Selbach, Uta ^a   Hermanns, Henning ^a   Stegmann, Jens Ulrich ^a   Kollosche, Kathrin ^b   Freynhagen, Rainer ^a   Bauer, Inge ^a   Lipfert, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic constriction injury; Formalin test; Glycine; Lidocaine; Nociception; Pathological pain

Indexed keywords

GLYCINE RECEPTOR; LIDOCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SYSTEMIC THERAPY;

ANALGESICS; ANIMALS; BINDING SITES; GLYCINE; GLYCINE AGENTS; LIDOCAINE; PAIN; PHOSPHONIC ACIDS; QUINOXALINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE; SPINAL CORD; SUBSTRATE SPECIFICITY; SYNAPTIC TRANSMISSION;

EID: 65749098418     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.043     Document Type: Article

References (53)

1. Abram S., and Yaksh T. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 80 (1994) 383-391
2. Ahmadi S., Muth-Selbach U., Lauterbach A., Lipfert P., Neuhuber W.L., and Zeilhofer H.U. Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science 300 (2003) 2094-2097
3. Amir R., Argoff C.E., Bennett G.J., Cummins T.R., Durieux M.E., Gerner P., Gold M.S., Porreca F., and Strichartz G.R. The role of sodium channels in chronic inflammatory and neuropathic pain. J. Pain 7 (2006) S1-S29
4. Araujo M.C., Sinnott C.J., and Strichartz G.R. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions. Pain 103 (2003) 21-29
5. Bach F.W., Jensen T.S., Kastrup J., Stigsby B., and Dejgard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 40 (1990) 29-34
6. Baranano D.E., Ferris C.D., and Snyder S.H. Atypical neural messengers. Trends Neurosci. 24 (2001) 99-106
7. Basbaum A. Distribution of glycine receptor immunoreactivity in the spinal cord of the rat: cytochemical evidence for a differential glycinergic control of lamina I and V nociceptive neurons. J. Comp. Neurol. 278 (1988) 330-336
8. Benkwitz C., Garrison J.C., Linden J., Durieux M.E., and Hollmann M.W. Lidocaine enhances G[alpha]i protein function. Anesthesiology 99 (2003) 1093-1101
9. Bennett G., and Xie Y. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
10. Biella G., and Sotgiu M.L. Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord. Brain Res. 603 (1993) 201-206
11. Biella G., Lacerenza M., Marchettini P., and Sotgiu M. Diverse modulation by systemic lidocaine of iontophoretic NMDA and quisqualic acid induced excitations on rat dorsal horn neurons. Neurosci. Lett. 157 (1993) 207-210
12. Cahana A., Carota A., Montadon M.-L., and Annoni J.M. The long-term effect of repeated intravenous lidocaine on central pain and possible correlation in positron emission tomography measurements. Anesth. Analg. 98 (2004) 1581-1584
13. Cairns B.E., Svensson P., Wang K., Hupfeld S., Graven-Nielsen T., Sessle B.J., Berde C.B., and Arendt-Nielsen L. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J. Neurophysiol. 90 (2003) 2098-2105
14. Carlton S.M., and Coggeshall R.E. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res. 820 (1999) 63-70
15. Chabal C., Russell L., and Burchiel K. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 38 (1989) 333-338
16. Challapalli V., Tremont-Lukats I., McNicol E., Lau J., and Carr D. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst. Rev. 4 (2005) CD003345
17. Childers W.E., and Baudy R.B. N-methyl-d-aspartate antagonists and neuropathic pain: the search for relief. J. Med. Chem. 50 (2007) 2557-2562
18. Chizh B.A., and Headley P.M. NMDA antagonists and neuropathic pain - multiple drug targets and multiple uses. Curr. Pharm. Des. 11 (2005) 2977-2994
19. Davidson E.M., Coggeshall R.E., and Carlton S.M. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport 8 (1997) 941-946
20. Devor M., Wall P.D., and Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 48 (1992) 261-268
21. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
22. Fan P., Oz M., Zhang L., and Weight F.F. Effect of cocaine on the 5-HT3 receptor-mediated ion current in Xenopus oocytes. Brain Res. 673 (1995) 181-184
23. Finnerup N.B., Biering-Sorensen F., Johannesen I.L., Terkelsen A.J., Juhl G.I., Kristensen A.D., Sindrup S.H., Bach F.W., and Jensen T.S. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology 102 (2005) 1023-1030
24. Hahnenkamp K., Durieux M.E., Hahnenkamp A., Schauerte S.K., Hoenemann C.W., Vegh V., Theilmeier G., and Hollmann M.W. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C. Br. J. Anaesth. 96 (2006) 77-87
25. Hara K., and Sata T. The effects of the local anesthetics lidocaine and procaine on glycine and gamma-aminobutyric acid receptors expressed in Xenopus oocytes. Anesth. Analg. 104 (2007) 1434-1439
26. Hara M., Kai Y., and Ikemoto Y. Local anesthetics reduce the inhibitory neurotransmitter-induced current in dissociated hippocampal neurons of the rat. Eur. J. Pharmacol. 283 (1995) 83-89
27. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
28. Hermanns H., Muth-Selbach U., Williams R., Krug S., Lipfert P., Werdehausen R., Braun S., and Bauer I. Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain. Neurosci. Lett. 445 (2008) 214-219
29. Hilgier W., Oja S.S., Saransaari P., and Albrecht J. A novel glycine site-specific N-methyl-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia. Brain Res. 1015 (2004) 186-188
30. Hollmann M.W., and Durieux M.E. Local anesthetics and the inflammatory response: a new therapeutic indication?. Anesthesiology 93 (2000) 858-875
31. Hollmann M.W., Kurz K., Herroeder S., Struemper D., Hahnenkamp K., Berkelmans N.S., den Bakker C.G., and Durieux M.E. The effects of S(-)-, R(+)-, and racemic bupivacaine on lysophosphatidate-induced priming of human neutrophils. Anesth. Analg. 97 (2003) 1053-1058
32. Hollmann M.W., Herroeder S., Kurz K.S., Hoenemann C.W., Struemper D., Hahnenkamp K., and Durieux M.E. Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics. Anesthesiology 100 (2004) 852-860
33. Holthusen H., Irsfeld S., and Lipfert P. Effect of pre- or post-traumatically applied i.v. lidocaine on primary and secondary hyperalgesia after experimental heat trauma in humans. Pain 88 (2000) 295-302
34. Jänig W. What is the mechanism underlying treatment of pain by systemic application of lidocaine?. Pain 137 (2008) 5-6
35. Jansen M., and Dannhardt G. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Eur. J. Med. Chem. 38 7-8 (2003) 661-670
36. Kastrup J., Petersen P., Dejgard A., Angelo H.R., and Hilsted J. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy?. Pain 28 (1987) 69-75
37. Kemp J.A., Foster A.C., Lesson P.D., Priestley T., Tridgett R., Iversen L.L., and Woodruff G.N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-d-aspartate receptor complex. PNAS 85 (1988) 6547-6550
38. Kleckner N., and Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241 (1988) 835-837
39. Lawand N.B., Willis W.D., and Westlund K.N. Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur. J. Pharmacol. 324 (1997) 169-177
40. Legendre P. The glycinergic inhibitory synapse. Cell. Mol. Life Sci. 58 (2001) 760-793
41. Mao J., and Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain 87 (2000) 7-17
42. McRoberts J.A., Coutinho S.V., Marvizon J.C.G., Grady E.F., Tognetto M., Sengupta J.N., Ennes H.S., Chaban V.V., Amadesi S., Creminon C., Lanthorn T., Geppetti P., Bunnett N.W., and Mayer E.A. Role of peripheral N-methyl-d-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120 (2001) 1737-1748
43. Muth-Selbach U.S., Tegeder I., Brune K., and Geisslinger G. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 91 (1999) 231-239
44. Muth-Selbach U., Dybek E., Kollosche K., Stegmann J., Holthusen H., Lipfert P., and Zeilhofer H.U. The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by d-serine. Anesthesiology 101 (2004) 753-758
45. Nishizawa N., Shirasaki T., Nakao S., Matsuda H., and Shingu K. The inhibition of the N-methyl-d-aspartate receptor channel by local anesthetics in mouse CA1 pyramidal neurons. Anesth. Analg. 94 (2002) 325-330
46. Schaible H. Peripheral and central mechanisms of pain generation. Handb. Exp. Pharmacol. 177 (2007) 3-28
47. Sugimoto M., Uchida I., Fukami S., Takenoshita M., Mashimo T., and Yoshiya I. The alpha and gamma subunit-dependent effects of local anesthetics on recombinant GABAA receptors. Eur. J. Pharmacol. 401 (2000) 329-337
48. Sugimoto M., Uchida I., and Mashimo T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-d-aspartate (NMDA) receptors. Br. J. Pharmacol. 138 (2003) 876-882
49. Tanelian D., and MacIver M. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 74 (1991) 934-936
50. van den Pol A., and Gorcs T. Glycine and glycine receptor immunoreactivity in brain and spinal cord. J. Neurosci. 8 (1988) 472-492
51. Woolf C., and Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 23 (1985) 361-374
52. Xiao W.H., and Bennett G.J. C-fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long-term infusion of lidocaine yielding nanogram per milliliter plasma levels. Pain 137 (2008) 218-228
53. Yanagidate F., and Strichartz G. Local anesthetics. Handb. Exp. Pharmacol. 177 (2007) 95-127